SLNSW-Standard chemotherapy with or without bevacizumab...-TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Full title: Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Author/creator: Stark, Dan, Dr, Nankivell, Matthew, MSc, Pujade-Lauraine, Eric, Prof, Kristensen, Gunnar, MD, Elit, Lorraine, MD, Stockler, Martin, MBBS, Hilpert, Felix, MD, Cervantes, Andrés, MD, Brown, Julia, MSc, Lanceley, Anne, PhD, Velikova, Galina, Prof, Sabate, Eduardo, MD, Pfisterer, Jacobus, Prof, Carey, Mark S, MD, Beale, Philip, MBBS, Qian, Wendi, PhD, Swart, Ann Marie, MRCP, Oza, Amit, FRCP, Perren, Tim, MD.

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

    Record identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

    Share

    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

    Full title

    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

    Author / Creator

    Stark, Dan, Dr ; Nankivell, Matthew, MSc ; Pujade-Lauraine, Eric, Prof ; Kristensen, Gunnar, MD ; Elit, Lorraine, MD ; Stockler, Martin, MBBS ; Hilpert, Felix, MD ; Cervantes, Andrés, MD ; Brown, Julia, MSc ; Lanceley, Anne, PhD ; Velikova, Galina, Prof ; Sabate, Eduardo, MD ; Pfisterer, Jacobus, Prof ; Carey, Mark S, MD ; Beale, Philip, MBBS ; Qian, Wendi, PhD ; Swart, Ann Marie, MRCP ; Oza, Amit, FRCP ; Perren, Tim, MD

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2013, Vol.14 (3), p.236-243

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Aged Analysis Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antimitotic agents Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Bevacizumab Cancer Chemotherapy Clinical trials Disease-Free Survival Drug-Related Side Effects and Adverse Reactions - chemically induced Drug-Related Side Effects and Adverse Reactions - pathology Female Health aspects Hematology, Oncology and Palliative Medicine Humans Medical informatics Middle Aged Neoplasm Staging Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Product development Quality of Life Treatment Outcome Universities and colleges Women

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3596061

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections